Offer new treatments only as part of post-market trials until data on meaningful outcomes are available, says Ben Goldacre to BMJ

No Comments
Watch the video from the BMJ channel below:

Next PostNewer Post Previous PostOlder Post Home

0 comments:

Post a Comment